CIS-DIAMMINEDICHLOROPLATINUM II
Duffy Blood Group, Chemokine Receptor Gene C.-67T>C
Andrew Hantel, MDSmall moleculePhase 1Active
CC
41/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 81/ 100
Competitive context
3 Active assets in the Duffy Blood Group, Chemokine Receptor Gene C.-67T>C cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
PREDNISONE TABLETS Andrew Hantel, MD | Phase 1 | CC |
FILGRASTIM Andrew Hantel, MD | Phase 1 | CC |
Epirubicin Andrew Hantel, MD | Phase 1 | CC |
Same molecule, other indications
CIS-DIAMMINEDICHLOROPLATINUM II is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →